ASP Isotopes Inc. (NASDAQ:ASPI – Get Free Report) was the recipient of a significant increase in short interest in the month of April. As of April 15th, there was short interest totalling 722,000 shares, an increase of 52.1% from the March 31st total of 474,600 shares. Based on an average daily volume of 638,000 shares, the days-to-cover ratio is currently 1.1 days. Currently, 3.2% of the shares of the stock are sold short.
Insider Transactions at ASP Isotopes
In other ASP Isotopes news, Director Robert John Andrew Ryan purchased 15,596 shares of ASP Isotopes stock in a transaction on Monday, January 29th. The shares were acquired at an average cost of $2.35 per share, for a total transaction of $36,650.60. Following the completion of the transaction, the director now directly owns 537,055 shares of the company’s stock, valued at $1,262,079.25. The purchase was disclosed in a filing with the SEC, which is available at this link. Insiders own 26.30% of the company’s stock.
Hedge Funds Weigh In On ASP Isotopes
An institutional investor recently bought a new position in ASP Isotopes stock. HTLF Bank purchased a new position in ASP Isotopes Inc. (NASDAQ:ASPI – Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm purchased 78,538 shares of the company’s stock, valued at approximately $141,000. HTLF Bank owned 0.16% of ASP Isotopes at the end of the most recent reporting period. 16.80% of the stock is currently owned by institutional investors.
ASP Isotopes Stock Up 1.8 %
ASP Isotopes (NASDAQ:ASPI – Get Free Report) last posted its earnings results on Wednesday, April 10th. The company reported ($0.09) earnings per share for the quarter. The company had revenue of $0.43 million for the quarter. As a group, research analysts anticipate that ASP Isotopes will post -0.11 EPS for the current year.
Analysts Set New Price Targets
Separately, HC Wainwright lifted their price objective on ASP Isotopes from $5.25 to $5.50 and gave the stock a “buy” rating in a report on Wednesday, April 17th.
Read Our Latest Stock Report on ASPI
ASP Isotopes Company Profile
ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.
Featured Stories
- Five stocks we like better than ASP Isotopes
- The Most Important Warren Buffett Stock for Investors: His Own
- MarketBeat Week in Review – 4/22 – 4/26
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- 3 Stocks Leading the U.S. Agriculture Comeback
- What is a Secondary Public Offering? What Investors Need to Know
- How to Use Put Debit Spreads to Profit From Falling Stocks
Receive News & Ratings for ASP Isotopes Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ASP Isotopes and related companies with MarketBeat.com's FREE daily email newsletter.